Stephen E. Sallan

Stephen E. Sallan

Pediatrics

450 Brookline Avenue
Room 1642
Boston, MA 02215

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 79 publications

Pegaspargase Rechallenge Following Grade 2 Hypersensitivity Reaction in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 16-001.

Pegaspargase Rechallenge Following Grade 2 Hypersensitivity Reaction in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 16-001.

Journal: Pediatric blood & cancer

Published: March 13, 2026

Genetic Determinants of Treatment-Related Bone Toxicity in Pediatric Acute Lymphoblastic Leukemia.

Genetic Determinants of Treatment-Related Bone Toxicity in Pediatric Acute Lymphoblastic Leukemia.

Journal: Clinical pharmacology and therapeutics

Published: February 06, 2026

Cardiovascular signaling proteins as predictors of the cardiac effects of doxorubicin treatment in children with acute lymphoblastic leukemia.

Cardiovascular signaling proteins as predictors of the cardiac effects of doxorubicin treatment in children with acute lymphoblastic leukemia.

Journal: Cardio-oncology (London, England)

Published: November 25, 2025

Mutational analysis of the mitochondrial tRNA genes and flanking regions in lymphocytes from long-term pediatric cancer survivors given doxorubicin chemotherapy for acute lymphoblastic leukemia.

Mutational analysis of the mitochondrial tRNA genes and flanking regions in lymphocytes from long-term pediatric cancer survivors given doxorubicin chemotherapy for acute lymphoblastic leukemia.

Journal: Cardio-oncology (London, England)

Published: June 05, 2025

Overweight or Obesity and Outcomes in Children With Acute Lymphoblastic Leukemia.

Overweight or Obesity and Outcomes in Children With Acute Lymphoblastic Leukemia.

Journal: JAMA network open

Published: May 14, 2025

Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen.

Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen.

Journal: Blood cancer journal

Published: July 31, 2024

Principles in the Development of Contemporary Treatment of Childhood Malignancies: The First 75 Years.

Principles in the Development of Contemporary Treatment of Childhood Malignancies: The First 75 Years.

Journal: Cold Spring Harbor perspectives in medicine

Published: July 15, 2024

Genome-wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemia.

Genome-wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemia.

Journal: British journal of haematology

Published: May 23, 2024

Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols.

Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols.

Journal: Leukemia

Published: June 05, 2023

Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials.

Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials.

Journal: Blood advances

Published: February 15, 2023

Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium.

Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium.

Journal: Pediatric blood & cancer

Published: February 10, 2023

Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001.

Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001.

Journal: Pediatric blood & cancer

Published: September 01, 2021

Showing 1-12 of 79

Last Updated: 09/26/2026